Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ferrari

Showing results (461-470 of 547) with videos related to

Pageof 55
Sort By:
International Journal of Molecular Sciences|February 29, 2020
Ticagrelor Increases <i>SIRT1</i> and <i>HES1</i> mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary DiseaseGiorgio Aquila, Francesco Vieceli Dalla Sega, Luisa Marracino, et al.
Journal of Hypertension|March 17, 2016
Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of HypertensionPaolo Palatini, Enrico Agabiti Rosei, Edoardo Casiglia, et al.
International Journal of Cardiology|January 12, 2015
Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPAJoep van der Leeuw, Rohit M Oemrawsingh, Yolanda van der Graaf, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 23, 2009
Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocolGiampaolo Niccoli, Domenico D'amario, Cristina Spaziani, et al.
Thrombosis and Haemostasis|March 24, 2017
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary diseaseGianluca Campo, Francesco Vieceli Dalla Sega, Rita Pavasini, et al.
European Heart Journal|April 30, 2005
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profileMarco Valgimigli, Gian Matteo Rigolin, Corrado Cittanti, et al.
Cardiovascular Drugs and Therapy|June 19, 2008
Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol designMarco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.
International Journal of Cardiology|September 6, 2020
Corrigendum to "Trimetazidine in cardiovascular medicine," [Int. J. Cardiol., 293 (2019) 39-44]Mario Marzilli, Dragos Vinereanu, Gary Lopaschuk, et al.
Molecular Cell|November 25, 2019
TFIIIC Binding to Alu Elements Controls Gene Expression via Chromatin Looping and Histone AcetylationRoberto Ferrari, Lara Isabel de Llobet Cucalon, Chiara Di Vona, et al.
Journal of Translational Medicine|May 6, 2017
Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: a pilot studyGiorgio Aquila, Cinzia Fortini, Antonio Pannuti, et al.
Pageof 55

Showing results (461-470 of 547) with videos related to

Sort By:
Pageof 55
International Journal of Molecular Sciences|February 29, 2020
Ticagrelor Increases <i>SIRT1</i> and <i>HES1</i> mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary DiseaseGiorgio Aquila, Francesco Vieceli Dalla Sega, Luisa Marracino, et al.
Journal of Hypertension|March 17, 2016
Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of HypertensionPaolo Palatini, Enrico Agabiti Rosei, Edoardo Casiglia, et al.
International Journal of Cardiology|January 12, 2015
Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPAJoep van der Leeuw, Rohit M Oemrawsingh, Yolanda van der Graaf, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 23, 2009
Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocolGiampaolo Niccoli, Domenico D'amario, Cristina Spaziani, et al.
Thrombosis and Haemostasis|March 24, 2017
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary diseaseGianluca Campo, Francesco Vieceli Dalla Sega, Rita Pavasini, et al.
European Heart Journal|April 30, 2005
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profileMarco Valgimigli, Gian Matteo Rigolin, Corrado Cittanti, et al.
Cardiovascular Drugs and Therapy|June 19, 2008
Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol designMarco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.
International Journal of Cardiology|September 6, 2020
Corrigendum to "Trimetazidine in cardiovascular medicine," [Int. J. Cardiol., 293 (2019) 39-44]Mario Marzilli, Dragos Vinereanu, Gary Lopaschuk, et al.
Molecular Cell|November 25, 2019
TFIIIC Binding to Alu Elements Controls Gene Expression via Chromatin Looping and Histone AcetylationRoberto Ferrari, Lara Isabel de Llobet Cucalon, Chiara Di Vona, et al.
Journal of Translational Medicine|May 6, 2017
Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: a pilot studyGiorgio Aquila, Cinzia Fortini, Antonio Pannuti, et al.
Pageof 55